Sun Pharmaceutical Industries Share Price Today - Live Blog for November 26, 2025

With a remarkable 0.05% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,806.35. Notably, this stock has a Price-to-Earnings (PE) ratio of 40.5400, while the industry's PE ratio is 32.8583.

Following a noteworthy 0.10% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,806.35. When it comes to valuation, this stock has a PE ratio of 40.5400, with the industry PE ratio at 32.8583.

After a notable 0.04% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,806.60. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.02% increase and currently trading at ₹1,803.80 per share. This upward trajectory is turning heads in the market.

Sun Pharmaceutical Industries Ltd witnessed a -0.11% decrease in its share price, and it is currently trading at ₹1,802.20. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 40.5400, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

After a notable 0.10% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,803.40. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.07% increase. Presently, it is actively trading at ₹1,802.00.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.07% recently. As of now, this stock is actively trading at a current market price of ₹1,801.70 per share, attracting attention from investors.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.18% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,799.30 per share. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

After a -0.07% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,796.00. The stock has a PE ratio of 40.5400, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.07%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,796.00, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.33% uptick, and they are currently valued at ₹1,797.30, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.08%, with the current market value at ₹1,791.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.09% decline and is currently trading at ₹1,793.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.21%, reaching a current market price of ₹1,794.60. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.08% increase and currently trading at ₹1,798.45 per share. Investors are taking notice of this upward momentum.

With a remarkable 0.21% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,797.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 40.5400, while the industry's PE ratio is 32.8583.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.08%, reaching the current market price of ₹1,793.00. This ascent signifies increased investor sentiment. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.17% increase and currently trading at ₹1,790.75 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.05%, reaching a current market price of ₹1,787.65. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.32%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,788.40, and market participants are assessing the implications. The stock has a PE ratio of 40.5400, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.30%, reaching the current market price of ₹1,794.10. This surge is indicative of the stock's recent positive performance.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.30%, reaching the current market price of ₹1,794.10. This ascent signifies increased investor sentiment. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.27% upswing and is currently trading at ₹1,787.20, indicating strong market sentiment.

With a -0.12% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,782.95. This development raises questions about the factors behind the decline. The stock's PE ratio is 40.5400, while the industry PE is 32.8583.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.31% surge in its share price and is presently trading at ₹1,785.90. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.26% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,780.30, making it an appealing option for investors.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.28%, a development that warrants careful analysis. Presently trading at ₹1,774.00, investors are assessing whether this presents an opportunity or a risk.